Angry GM stalemate in Germany

Political parties and legislative bodies seem unable to resolve their dispute over GM crops

Written byGrit Kienzlen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Germany's two national legislative bodies were at loggerheads over genetically modified (GM) plant legislation yesterday (September 22) after an arbitration panel that is supposed to conciliate between the Parliament and Bundesrat failed to reach a consensus.

On July 9, the representatives of Germany's 16 provinces in the Bundesrat—dominated by the Christian Democrat party—defeated a bill that had been approved by the Parliament (Bundestag), where Social Democrat (SPD) and Green parties hold the majority.

The arbitration panel is supposed to mediate between Bundestag and Bundesrat, but "the talks there are still extremely emotionally charged," Wolf-Dieter Glatzel, who represents the SPD faction in the panel, told The Scientist. Each party accuses the other of irrationality, as they struggle to draft a law that will allow commercial use of plant biotechnology while being acceptable to opponents of the technology.

Originally, the federal government was supposed to implement EU guidelines for releasing GM plants ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies